WallStreetZenWallStreetZen

NYSE: ENOV
Enovis Corp Stock

Overview
ForecastEarningsRevenueDividendOwnership
$33.32+0.98 (+3.03%)
Updated Sep 16, 2025
ENOV Price
$33.32
Fair Value Price
N/A
Market Cap
$1.90B
52 Week Low
$25.47
52 Week High
$49.83
P/E
-2.24x
P/B
0.74x
P/S
0.88x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.19B
Earnings
-$827.56M
Gross Margin
57.6%
Operating Margin
-34.67%
Profit Margin
-37.8%
Debt to Equity
0.95
Operating Cash Flow
$188M
Beta
1.23
Next Earnings
Oct 30, 2025
Ex-Dividend
N/A
Next Dividend
N/A

ENOV Overview

Enovis Corporation is a medical technology company focused on orthopedics. It manufactures medical devices for patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, or sports-related injuries. Formerly known as Colfax Corporation, Enovis was founded in 1995 and is headquartered in Wilmington, DE.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ENOV's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

B
Value
B
Growth
D
Momentum
C
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Specialty Industrial Machinery

Industry Rating
A
ENOV
Ranked#34 of 71

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Gorman Rupp Co (GRC)
$43.33A
Taylor Devices (TAYD)
$47.01A
Power Solutions International (PSIX)
$98.42A
View Top Specialty Industrial Machinery Stocks

Be the first to know about important ENOV news, forecast changes, insider trades & much more!

ENOV News

Overview

Due Diligence Score

–
Industry Average (36)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ENOV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ENOV is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ENOV is good value based on its book value relative to its share price (0.74x), compared to the US Specialty Industrial Machinery industry average (6.29x)
P/B vs Industry Valuation
ENOV is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ENOV due diligence checks available for Premium users.

Valuation

ENOV price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-2.24x
Industry
17.19x
Market
37.55x

ENOV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.74x
Industry
6.29x
ENOV is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ENOV's financial health

Profit margin

Revenue
$564.5M
Net Income
-$36.7M
Profit Margin
-6.5%
ENOV's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ENOV's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$5.0B
Liabilities
$2.4B
Debt to equity
0.95
ENOV's short-term assets ($1.28B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ENOV's long-term liabilities ($1.87B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ENOV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ENOV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$47.8M
Investing
-$49.8M
Financing
$6.2M
ENOV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ENOV vs Specialty Industrial Machinery Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ENOVC$1.90B+3.03%-2.24x0.74x
HLIOB$1.80B-0.13%52.23x1.98x
HIC$1.74B+0.04%-95.15x1.32x
PSIXA$2.26B+3.03%27.88x26.85x
EPACB$2.27B-0.87%25.68x5.18x
View Top Specialty Industrial Machinery Stocks

Enovis Stock FAQ

What is Enovis's quote symbol?

(NYSE: ENOV) Enovis trades on the NYSE under the ticker symbol ENOV. Enovis stock quotes can also be displayed as NYSE: ENOV.

If you're new to stock investing, here's how to buy Enovis stock.

What is the 52 week high and low for Enovis (NYSE: ENOV)?

(NYSE: ENOV) Enovis's 52-week high was $49.83, and its 52-week low was $25.47. It is currently -33.13% from its 52-week high and 30.82% from its 52-week low.

How much is Enovis stock worth today?

(NYSE: ENOV) Enovis currently has 57,159,803 outstanding shares. With Enovis stock trading at $33.32 per share, the total value of Enovis stock (market capitalization) is $1.90B.

Enovis stock was originally listed at a price of $63.00 in May 8, 2008. If you had invested in Enovis stock at $63.00, your return over the last 17 years would have been -47.11%, for an annualized return of -3.68% (not including any dividends or dividend reinvestments).

How much is Enovis's stock price per share?

(NYSE: ENOV) Enovis stock price per share is $33.32 today (as of Sep 16, 2025).

What is Enovis's Market Cap?

(NYSE: ENOV) Enovis's market cap is $1.90B, as of Sep 17, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Enovis's market cap is calculated by multiplying ENOV's current stock price of $33.32 by ENOV's total outstanding shares of 57,159,803.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.